News

Published on 16 Feb 2024 on Motley Fool via Yahoo Finance

Wall Street Thinks These 3 Stocks Are Hidden Gems That Could Soar 43% to 59% Over the Next 12 Months


Article preview image

Some stocks seem to hog the limelight, and that's understandable, to some extent. After all, stocks that have been at the forefront of the hottest trends and delivered tremendous gains arguably deserve greater attention than others.

However, this also means that investors can find great opportunities with stocks that aren't at the center of attention. Wall Street thinks these three stocks are hidden gems that could soar 43% to 59% higher over the next 12 months.

NASDAQ.RPRX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Royalty Pharma (NASDAQ:RPRX) Will Pay A Dividend Of $0.21

The board of Royalty Pharma plc (NASDAQ:RPRX) has announced that it will pay a dividend of $0.21 ...

Simply Wall St. via Yahoo Finance 20 Apr 2024

Royalty Pharma plc's (NASDAQ:RPRX) Stock Has Shown A Decent Performance: Have Financials A Role To...

Royalty Pharma's (NASDAQ:RPRX) stock up by 8.1% over the past three months. Given that stock pric...

Simply Wall St. via Yahoo Finance 30 Mar 2024

Wall Street Thinks These 3 Stocks Are Hidden Gems That Could Soar 43% to 59% Over the Next 12 Months

Some stocks seem to hog the limelight, and that's understandable, to some extent. After all, stoc...

Motley Fool via Yahoo Finance 16 Feb 2024

Royalty Pharma plc (NASDAQ:RPRX) Q4 2023 Earnings Call Transcript

Royalty Pharma plc (NASDAQ:RPRX) Q4 2023 Earnings Call Transcript February 15, 2024 Royalty Pharm...

Insider Monkey via Yahoo Finance 16 Feb 2024

Royalty Pharma PLC (RPRX): A Strategic SWOT Insight

Robust market share with a 58% stake in biopharmaceutical royalty transactions from 2012 through ...

GuruFocus.com via Yahoo Finance 16 Feb 2024

What Makes Royalty Pharma plc (RPRX) a Compelling Stock?

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equ...

Insider Monkey via Yahoo Finance 31 Jan 2024

Should You Sell Royalty Pharma plc (RPRX)?

TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid C...

Insider Monkey via Yahoo Finance 14 Dec 2023

Royalty Pharma plc (NASDAQ:RPRX) is a favorite amongst institutional investors who own 69%

Key Insights Given the large stake in the stock by institutions, Royalty Pharma's stock price mig...

Simply Wall St. via Yahoo Finance 26 Nov 2023

The Royalty Pharma PLC (RPRX) Company: A Short SWOT Analysis

Strengths: Diverse portfolio with royalties on over 35 commercial products and a robust pipeline ...

GuruFocus.com via Yahoo Finance 9 Nov 2023

Are Royalty Pharma plc's (NASDAQ:RPRX) Mixed Financials Driving The Negative Sentiment?

With its stock down 10% over the past three months, it is easy to disregard Royalty Pharma (NASDA...

Simply Wall St. via Yahoo Finance 7 Sep 2023